Moclobemide and selegeline in the treatment of depression in Parkinson's disease

Ítems similars

• Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Stopping selegeline may lead to problems for patients.
  per: Anderson, K. E., et al.
  Publicat: (1996)
• Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Selegeline is effective and safe in early stages.
  per: MacMahon, D. G., et al.
  Publicat: (1996)
• Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Selegeline may be toxic in presence of increased dopamine concentrations.
  per: Yu, P. H., et al.
  Publicat: (1996)
• Moclobemide versus fluoxetine in the treatment of major depressive disorder in adults.
  per: Lapierre, Y D, et al.
  Publicat: (1997)
• Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Parkinson's disease is rarely a primary cause of death.
  per: Silva, M. T., et al.
  Publicat: (1996)